Yu‐Yin Shih

479 total citations
19 papers, 357 citations indexed

About

Yu‐Yin Shih is a scholar working on Molecular Biology, Neurology and Cell Biology. According to data from OpenAlex, Yu‐Yin Shih has authored 19 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Neurology and 5 papers in Cell Biology. Recurrent topics in Yu‐Yin Shih's work include Neuroblastoma Research and Treatments (6 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Redox biology and oxidative stress (3 papers). Yu‐Yin Shih is often cited by papers focused on Neuroblastoma Research and Treatments (6 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Redox biology and oxidative stress (3 papers). Yu‐Yin Shih collaborates with scholars based in Taiwan, Japan and Australia. Yu‐Yin Shih's co-authors include Bo‐Jeng Wang, Hsinyu Lee, Wen‐Ming Hsu, Yung‐Feng Liao, Wen‐Ta Su, Yung‐Ming Jeng, Hsueh‐Fen Juan, Yeou‐Guang Tsay, Andy Chao Hsuan Lee and Amanda L. Bain and has published in prestigious journals such as PLoS ONE, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Yu‐Yin Shih

18 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu‐Yin Shih Taiwan 11 173 60 49 48 47 19 357
Nevena Zogović Serbia 15 277 1.6× 43 0.7× 88 1.8× 28 0.6× 34 0.7× 23 542
Hui-fen Zheng China 6 194 1.1× 67 1.1× 20 0.4× 34 0.7× 45 1.0× 8 491
Tsung‐Lang Chiu Taiwan 13 241 1.4× 55 0.9× 44 0.9× 33 0.7× 19 0.4× 32 547
Jennifer S. Waby United Kingdom 10 318 1.8× 52 0.9× 69 1.4× 24 0.5× 42 0.9× 12 500
Feng Jiao China 15 193 1.1× 64 1.1× 29 0.6× 48 1.0× 11 0.2× 37 491
Şeyma Demirsoy Belgium 7 168 1.0× 32 0.5× 43 0.9× 47 1.0× 55 1.2× 8 320
Lili Chi China 12 185 1.1× 62 1.0× 43 0.9× 45 0.9× 11 0.2× 29 447
Xuan Zheng China 13 255 1.5× 33 0.6× 38 0.8× 34 0.7× 24 0.5× 33 515
Jianshuang Guo China 10 153 0.9× 23 0.4× 20 0.4× 50 1.0× 19 0.4× 24 396

Countries citing papers authored by Yu‐Yin Shih

Since Specialization
Citations

This map shows the geographic impact of Yu‐Yin Shih's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Yin Shih with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Yin Shih more than expected).

Fields of papers citing papers by Yu‐Yin Shih

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Yin Shih. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Yin Shih. The network helps show where Yu‐Yin Shih may publish in the future.

Co-authorship network of co-authors of Yu‐Yin Shih

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Yin Shih. A scholar is included among the top collaborators of Yu‐Yin Shih based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Yin Shih. Yu‐Yin Shih is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Liu, Yu‐Chin, Kowit‐Yu Chong, Guanying Chen, et al.. (2025). Targeting the ERK1/2 and p38 MAPK pathways attenuates Golgi tethering factor golgin-97 depletion-induced cancer progression in breast cancer. Cell Communication and Signaling. 23(1). 22–22. 5 indexed citations
2.
Shih, Yu‐Yin, et al.. (2024). Synergistic effects of fibrin-enriched adipose decellularized extracellular matrix (AdECM) and microfluidic model on vascularization. RSC Advances. 14(46). 34143–34155. 2 indexed citations
3.
Shih, Yu‐Yin, et al.. (2024). Preliminary study of utilizing a patient derived tumor spheroid model to augment precision therapy in metastatic brain tumors. Scientific Reports. 14(1). 31888–31888. 2 indexed citations
4.
Wu, Chih‐Ching, Yu‐Yin Shih, Pei‐Chun Hsueh, et al.. (2024). Exploration of influenza A virus PA protein-associated cellular proteins discloses its impact on mitochondrial function. Virus Research. 345. 199387–199387. 1 indexed citations
6.
Shih, Yu‐Yin, et al.. (2022). S-glutathionylation of Hsp90 enhances its degradation and correlates with favorable prognosis of breast cancer. Redox Biology. 57. 102501–102501. 11 indexed citations
8.
Shih, Yu‐Yin, Fanfan Zhou, Tzu‐Chieh Chao, et al.. (2019). Calreticulin regulates MYCN expression to control neuronal differentiation and stemness of neuroblastoma. Journal of Molecular Medicine. 97(3). 325–339. 4 indexed citations
9.
Raninga, Prahlad V., Andy Chao Hsuan Lee, Debottam Sinha, et al.. (2019). Therapeutic cooperation between auranofin, a thioredoxin reductase inhibitor and anti‐PD‐L1 antibody for treatment of triple‐negative breast cancer. International Journal of Cancer. 146(1). 123–136. 70 indexed citations
10.
Shih, Yu‐Yin, Yu‐Chen Huang, Zhijay Tu, et al.. (2016). Metabolic labelling of cholesteryl glucosides in Helicobacter pylori reveals how the uptake of human lipids enhances bacterial virulence. Chemical Science. 7(9). 6208–6216. 26 indexed citations
11.
Shih, Yu‐Yin & Chun‐Hung Lin. (2015). S‐Glutathionylation promotes HSP90 degradation under oxidative stress. The FASEB Journal. 29(S1). 2 indexed citations
12.
Wu, Pei‐Yi, Yung-Feng Liao, Hsueh‐Fen Juan, et al.. (2014). Aryl Hydrocarbon Receptor Downregulates MYCN Expression and Promotes Cell Differentiation of Neuroblastoma. PLoS ONE. 9(2). e88795–e88795. 28 indexed citations
13.
14.
Su, Wen‐Ta, et al.. (2012). Microgrooved patterns enhanced PC12 cell growth, orientation, neurite elongation, and neuritogenesis. Journal of Biomedical Materials Research Part A. 101A(1). 185–194. 53 indexed citations
15.
Shih, Yu‐Yin, Hsinyu Lee, Akira Nakagawara, et al.. (2011). Nuclear GRP75 Binds Retinoic Acid Receptors to Promote Neuronal Differentiation of Neuroblastoma. PLoS ONE. 6(10). e26236–e26236. 24 indexed citations
16.
Shih, Yu‐Yin, Akira Nakagawara, Hsinyu Lee, et al.. (2011). Calreticulin Mediates Nerve Growth Factor-Induced Neuronal Differentiation. Journal of Molecular Neuroscience. 47(3). 571–581. 14 indexed citations
17.
Chang, Hsiu‐Hao, Hsinyu Lee, Po‐Nien Tsao, et al.. (2010). Notch1 Expression Predicts an Unfavorable Prognosis and Serves as a Therapeutic Target of Patients with Neuroblastoma. Clinical Cancer Research. 16(17). 4411–4420. 41 indexed citations
18.
Wing, Lih-Yuh C., et al.. (2009). Effects of Oral Estrogen on Aortic ROS-Generating and -Scavenging Enzymes and Atherosclerosis in apoE-Deficient Mice. Experimental Biology and Medicine. 234(9). 1037–1046. 30 indexed citations
19.
Hsu, Wen‐Ming, Hsinyu Lee, Hsueh‐Fen Juan, et al.. (2008). Identification of GRP75 as an Independent Favorable Prognostic Marker of Neuroblastoma by a Proteomics Analysis. Clinical Cancer Research. 14(19). 6237–6245. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026